MABG Consulting Group
Bridging the technical and commercial gap in Diagnostics and Life Science - from the Bench to the Boardroom
MABG Consulting Group brings together deep commercial, technical, and strategic expertise across the in vitro diagnostics (IVD), immunoassay, clinical chemistry and molecular diagnostics markets. Co-founded by seasoned industry leaders, the firm combines 20+ years of experience with a proven track record of scaling businesses from early-stage through commercial maturity, driving sustainable revenue growth, and building high-performing organizations aligned to long-term strategic goals.
Ready to unlock the market potential of your innovations? We'd love to learn about your project.
$30M+
Revenue Growth
Architected and executed go-to-market strategies that grew regional operations from $8M to over $30M.
$3M+
Non-Dilutive Funding Acquired
Secured millions in NIH & SBIR Phase II grants for commercialization of novel and highly technical platforms.
+600 Citations
High Impact Publications
Authored publications in highly respected foundational and translational journals, including:
Journal of Clinical Investigation (JCI)
Journal of Biological Chemistry (JBC)
Journal of Immunology
mBio
30+
Years of Experience
Combined expertise in the Biotech, IVD and Life Science fields, seamlessly bridging the bench to the boardroom.
-
The science is ready; the market is waiting →
MABG Consulting Groupwas founded to bridge a critical gap in the industry: some of the most transformative technology in diagnostics and life science never reach the people who need it most — not because the science isn't ready, but because the strategic path to market is missing.
We built MABG to change that. We are a specialized consulting group dedicated to helping IVD and biotech companies unlock the full commercial potential of their scientific innovations navigating the complex journey and supporting you from concept through commercialization.
-
We offer end-to-end commercial advisory services across four core areas:
Market Intelligence — Competitive analysis, industry landscaping, go-to-market planning, market entry strategy, and voice-of-customer research
Commercial Strategy — M&A due diligence, revenue growth acceleration, assay and product development alignment, SWOT analysis, and business analytics
Sales Enablement — Sales organization design and coaching, pipeline analysis, warm handoffs and contract selling
Brand & Messaging — Marketing collateral, content strategy, user experience, and branding
-
MABG was built by two professionals with a combined 20+ years of experience who have spent their careers at the intersection of science and commerce and who understand both sides deeply.
Led by CEO Mike Garofalo and CTO Arielle Bryan, MABG combines world-class commercial leadership with deep scientific innovation. Michael’s extensive experience driving transformative revenue growth and managing multimillion-dollar diagnostic portfolios perfectly complements Arielle’s unique ability to translate complex R&D (from qPCR to nanobody platforms) into scalable market strategies. By bridging the gap between high-level technical rigor and global operational scale, this executive duo ensures that every MABG solution is not only scientifically sound but also strategically positioned for rapid commercial success and long-term market impact.
MABG Consulting Group is differentiated by its hands-on approach, combining strategic vision with real-world execution experience to deliver measurable business outcomes for diagnostics and life sciences organizations.
Meet Our Leadership
Mike Garofalo
Co-Founder & Chief Executive Officer
-
Mike Garofalo (Chief Executive Officer), a commercial executive with extensive global experience, has led North American operations for multinational diagnostics organizations with full P&L responsibility and driven transformative revenue growth across global diagnostics businesses. He has built and scaled sales teams, developed multi-year strategic roadmaps, and managed multimillion-dollar portfolios spanning antibodies, antigens, molecular assays, and OEM partnerships. His leadership has consistently translated into double-digit growth, successful market expansion, and the launch of new business units, including molecular diagnostics platforms.
Arielle Bryan, PhD
Co-Founder & Chief Technical Officer
-
Complementing the commercial strength of our CEO, Arielle Bryan (Chief Technical Officer) brings a rare combination of Ph.D. level scientific expertise and frontline commercial experience. She has translated complex R&D innovations into scalable commercial strategies across qPCR, NGS, isothermal amplification, and diagnostics. From securing millions in NIH/SBIR funding to building North American pipelines from a near-zero baseline, she bridges the gap between science and strategy at the highest level. Her technical experience enables MABG to bridge critical gaps—ensuring that products are not only scientifically sound, but also positioned for market success.
Ready to unlock the market potential of your innovations?
We'd love to learn about your project!
Contact Us
Interested in working together, but not sure who to book time with? Fill out some info and we will be in touch shortly for a free consultation. We can’t wait to hear from you!